These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
Ontario, Canada
|
|
98-1220792
|
|
(State or other jurisdiction of incorporation or organization)
|
|
(IRS Employer Identification No.)
|
|
|
|
|
|
895 Don Mills Road, Bldg. 2, Suite 900
|
|
|
|
Toronto, Ontario, Canada, M3C 1W3
|
|
|
|
(Address of principal executive offices)
|
|
|
|
Title of Each Class
|
Trading Symbol(s)
|
Name of Each Exchange on Which Registered
|
|
Common Shares
|
ANY
|
NASDAQ Capital Market
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
Item 1.
|
|
|
Page
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
Item 2.
|
|
|
||
|
|
|
|
|
|
|
Item 3.
|
|
|
||
|
|
|
|
|
|
|
Item 4.
|
|
|
||
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
Item 1.
|
|
|
||
|
|
|
|
|
|
|
Item 1A.
|
|
|
||
|
|
|
|
|
|
|
Item 2.
|
|
|
||
|
|
|
|
|
|
|
Item 3.
|
|
|
||
|
|
|
|
|
|
|
Item 4.
|
|
|
||
|
|
|
|
|
|
|
Item 5.
|
|
|
||
|
|
|
|
|
|
|
Item 6.
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
Three Months
Ended March 31, |
||||||
|
|
2020
|
|
2019
|
||||
|
|
|
|
|
||||
|
|
(Unaudited)
|
||||||
|
Revenue
|
$
|
1,010
|
|
|
$
|
2,130
|
|
|
Cost of revenue
|
547
|
|
|
1,435
|
|
||
|
Gross profit
|
463
|
|
|
695
|
|
||
|
Operating expenses:
|
|
|
|
||||
|
Sales and marketing
|
304
|
|
|
453
|
|
||
|
Research and development
|
339
|
|
|
697
|
|
||
|
General and administrative
|
984
|
|
|
1,252
|
|
||
|
|
1,627
|
|
|
2,402
|
|
||
|
Loss from operations
|
(1,164
|
)
|
|
(1,707
|
)
|
||
|
Other income (expense):
|
|
|
|
||||
|
Interest expense, related party
|
—
|
|
|
(142
|
)
|
||
|
Interest expense
|
(9
|
)
|
|
(3
|
)
|
||
|
Other income, net
|
70
|
|
|
8
|
|
||
|
Net loss
|
(1,103
|
)
|
|
(1,844
|
)
|
||
|
Net loss per share:
|
|
|
|
||||
|
Basic and diluted
|
$
|
(0.28
|
)
|
|
$
|
(0.82
|
)
|
|
Shares used in computing net loss per share:
|
|
|
|
||||
|
Basic and diluted
|
3,947,657
|
|
|
2,236,590
|
|
||
|
|
Three Months
Ended March 31, |
||||||
|
|
2020
|
|
2019
|
||||
|
|
|
|
|
||||
|
|
(Unaudited)
|
||||||
|
Net loss
|
$
|
(1,103
|
)
|
|
$
|
(1,844
|
)
|
|
Other comprehensive (loss) income:
|
|
|
|
||||
|
Foreign currency translation adjustment
|
(71
|
)
|
|
40
|
|
||
|
Total other comprehensive (loss) income
|
(71
|
)
|
|
40
|
|
||
|
Comprehensive loss
|
$
|
(1,174
|
)
|
|
$
|
(1,804
|
)
|
|
|
March 31,
2020 |
|
December 31,
2019 |
||||
|
|
|
|
|
||||
|
Assets
|
(Unaudited)
|
||||||
|
Current assets:
|
|
|
|
||||
|
Cash and cash equivalents
|
$
|
285
|
|
|
$
|
149
|
|
|
Accounts receivable, net
|
335
|
|
|
369
|
|
||
|
Inventories
|
694
|
|
|
753
|
|
||
|
Other current assets
|
666
|
|
|
670
|
|
||
|
Total current assets
|
1,980
|
|
|
1,941
|
|
||
|
Investment in affiliate
|
2,100
|
|
|
2,100
|
|
||
|
Intangible assets, net
|
1,976
|
|
|
2,301
|
|
||
|
Goodwill
|
1,385
|
|
|
1,385
|
|
||
|
Other assets
|
616
|
|
|
679
|
|
||
|
Total assets
|
$
|
8,057
|
|
|
$
|
8,406
|
|
|
Liabilities and Shareholders’ Equity
|
|
|
|
||||
|
Current liabilities:
|
|
|
|
||||
|
Accounts payable
|
$
|
4,151
|
|
|
$
|
4,113
|
|
|
Accrued liabilities
|
659
|
|
|
475
|
|
||
|
Accrued payroll and employee compensation
|
339
|
|
|
340
|
|
||
|
Deferred revenue
|
914
|
|
|
1,069
|
|
||
|
Line of credit
|
491
|
|
|
491
|
|
||
|
Other current liabilities
|
196
|
|
|
158
|
|
||
|
Total current liabilities
|
6,750
|
|
|
6,646
|
|
||
|
Deferred revenue, long-term
|
365
|
|
|
485
|
|
||
|
Convertible debt
|
375
|
|
|
—
|
|
||
|
Convertible debt-related party
|
350
|
|
|
—
|
|
||
|
Other non-current liabilities
|
16
|
|
|
35
|
|
||
|
Total liabilities
|
7,856
|
|
|
7,166
|
|
||
|
Commitments and contingencies (Note 13)
|
|
|
|
|
|
||
|
Shareholders’ equity:
|
|
|
|
||||
|
Preferred shares, no par value, unlimited shares authorized, 8,443,778 shares issued and outstanding at both March 31, 2020 and December 31, 2019
|
8,444
|
|
|
8,444
|
|
||
|
Common shares, no par value; unlimited shares authorized, 4,016,825 and 3,850,105 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively
|
186,296
|
|
|
186,161
|
|
||
|
Accumulated other comprehensive loss
|
(1,840
|
)
|
|
(1,769
|
)
|
||
|
Accumulated deficit
|
(192,699
|
)
|
|
(191,596
|
)
|
||
|
Total shareholders’ equity
|
201
|
|
|
1,240
|
|
||
|
Total liabilities and shareholders’ equity
|
$
|
8,057
|
|
|
$
|
8,406
|
|
|
|
Three Months
Ended March 31, |
||||||
|
|
2020
|
|
2019
|
||||
|
|
|
|
|
||||
|
Operating activities:
|
(Unaudited)
|
||||||
|
Net loss
|
$
|
(1,103
|
)
|
|
$
|
(1,844
|
)
|
|
Adjustments to reconcile net loss to cash used in operating activities:
|
|
|
|
||||
|
Depreciation and amortization
|
247
|
|
|
267
|
|
||
|
Share-based compensation
|
5
|
|
|
124
|
|
||
|
Preferred shares interest expense-related party
|
—
|
|
|
130
|
|
||
|
Changes in operating assets and liabilities:
|
|
|
|
||||
|
Accounts receivable
|
34
|
|
|
282
|
|
||
|
Inventories
|
59
|
|
|
(16
|
)
|
||
|
Accounts payable and accrued liabilities
|
363
|
|
|
70
|
|
||
|
Accrued payroll and employee compensation
|
8
|
|
|
(62
|
)
|
||
|
Deferred revenue
|
(276
|
)
|
|
(191
|
)
|
||
|
Other assets and liabilities, net
|
224
|
|
|
250
|
|
||
|
Net cash used in operating activities
|
(439
|
)
|
|
(990
|
)
|
||
|
Financing activities:
|
|
|
|
||||
|
Proceeds from convertible debt
|
375
|
|
|
—
|
|
||
|
Proceeds from convertible debt-related party
|
200
|
|
|
—
|
|
||
|
Proceeds from debt - related party
|
—
|
|
|
523
|
|
||
|
Proceeds from line of credit, net
|
—
|
|
|
265
|
|
||
|
Net cash provided by financing activities
|
575
|
|
|
788
|
|
||
|
Net increase (decrease) in cash and cash equivalents
|
136
|
|
|
(202
|
)
|
||
|
Cash and cash equivalents, beginning of period
|
149
|
|
|
341
|
|
||
|
Cash and cash equivalents, end of period
|
$
|
285
|
|
|
$
|
139
|
|
|
Supplemental disclosures of cash flow information:
|
|
|
|
||||
|
Cash paid for interest
|
$
|
32
|
|
|
$
|
10
|
|
|
Supplemental disclosures of non-cash financing activities:
|
|
|
|
||||
|
Issuance of convertible debt-related party for prepaid business advisory services
|
$
|
150
|
|
|
$
|
—
|
|
|
Issuance of common shares for settlement of liabilities
|
$
|
130
|
|
|
$
|
—
|
|
|
Issuance of common shares for settlement of related party liabilities
|
$
|
—
|
|
|
$
|
105
|
|
|
|
Preferred Shares
|
|
Common Shares
|
|
Accumulated
Other Comprehensive Loss |
|
Accumulated
Deficit |
|
Total
Shareholders' Equity |
||||||||||||||||
|
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
|
|||||||||||||||||
|
Balance at January 1, 2020
|
8,443,778
|
|
|
$
|
8,444
|
|
|
3,850,105
|
|
|
$
|
186,161
|
|
|
$
|
(1,769
|
)
|
|
$
|
(191,596
|
)
|
|
$
|
1,240
|
|
|
Issuance of common shares pursuant to
the vesting of restricted stock units
|
—
|
|
|
—
|
|
|
20,420
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
Issuance of restricted stock awards for the
settlement of liabilities
|
—
|
|
|
—
|
|
|
146,300
|
|
|
130
|
|
|
—
|
|
|
—
|
|
|
130
|
|
|||||
|
Share-based compensation
|
—
|
|
|
—
|
|
|
—
|
|
|
5
|
|
|
—
|
|
|
—
|
|
|
5
|
|
|||||
|
Other comprehensive income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(71
|
)
|
|
—
|
|
|
(71
|
)
|
|||||
|
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,103
|
)
|
|
(1,103
|
)
|
|||||
|
Balance at March 31, 2020
|
8,443,778
|
|
|
$
|
8,444
|
|
|
4,016,825
|
|
|
$
|
186,296
|
|
|
$
|
(1,840
|
)
|
|
$
|
(192,699
|
)
|
|
$
|
201
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
Preferred Shares
|
|
Common Shares
|
|
Accumulated
Other Comprehensive Loss |
|
Accumulated
Deficit |
|
Total
Shareholders' Deficit |
||||||||||||||||
|
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
|
|||||||||||||||||
|
Balance at January 1, 2019
|
—
|
|
|
$
|
—
|
|
|
2,219,141
|
|
|
$
|
183,524
|
|
|
$
|
(1,816
|
)
|
|
$
|
(187,315
|
)
|
|
$
|
(5,607
|
)
|
|
Issuance of common shares pursuant to
the vesting of restricted stock units |
—
|
|
|
—
|
|
|
38,930
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
Issuance of restricted stock awards for the
settlement of liabilities |
—
|
|
|
—
|
|
|
42,000
|
|
|
105
|
|
|
—
|
|
|
—
|
|
|
105
|
|
|||||
|
Share-based compensation
|
—
|
|
|
—
|
|
|
—
|
|
|
124
|
|
|
—
|
|
|
—
|
|
|
124
|
|
|||||
|
Other comprehensive income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
40
|
|
|
—
|
|
|
40
|
|
|||||
|
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,844
|
)
|
|
(1,844
|
)
|
|||||
|
Balance at March 31, 2019
|
—
|
|
|
$
|
—
|
|
|
2,300,071
|
|
|
$
|
183,753
|
|
|
$
|
(1,776
|
)
|
|
$
|
(189,159
|
)
|
|
$
|
(7,182
|
)
|
|
1.
|
Organization and Business
|
|
2.
|
Significant Accounting Policies
|
|
3.
|
Certain Balance Sheet Items
|
|
|
March 31,
2020 |
|
December 31,
2019 |
||||
|
Raw materials
|
$
|
124
|
|
|
$
|
92
|
|
|
Work in process
|
165
|
|
|
137
|
|
||
|
Finished goods
|
405
|
|
|
524
|
|
||
|
|
$
|
694
|
|
|
$
|
753
|
|
|
|
March 31,
2020 |
|
December 31,
2019 |
||||
|
Transition service agreement
|
$
|
168
|
|
|
$
|
345
|
|
|
Deferred cost - service contracts
|
115
|
|
|
118
|
|
||
|
Prepaid insurance and services
|
378
|
|
|
207
|
|
||
|
Other
|
5
|
|
|
—
|
|
||
|
|
$
|
666
|
|
|
$
|
670
|
|
|
|
March 31,
2020 |
|
December 31,
2019 |
||||
|
Prepaid insurance and services
|
$
|
486
|
|
|
$
|
519
|
|
|
Deferred cost – service contracts
|
125
|
|
|
154
|
|
||
|
Other
|
5
|
|
|
6
|
|
||
|
|
$
|
616
|
|
|
$
|
679
|
|
|
4.
|
Intangible Assets
|
|
|
March 31,
2020 |
|
December 31,
2019 |
||||
|
Developed technology
|
$
|
13,323
|
|
|
$
|
13,323
|
|
|
Channel partner relationships
|
730
|
|
|
730
|
|
||
|
Capitalized development costs
(1)
|
2,779
|
|
|
3,047
|
|
||
|
Customer relationships
|
380
|
|
|
380
|
|
||
|
|
17,212
|
|
|
17,480
|
|
||
|
Accumulated amortization:
|
|
|
|
||||
|
Developed technology
|
(12,803
|
)
|
|
(12,682
|
)
|
||
|
Channel partner relationships
|
(385
|
)
|
|
(355
|
)
|
||
|
Capitalized development costs
(1)
|
(1,997
|
)
|
|
(2,094
|
)
|
||
|
Customer relationships
|
(331
|
)
|
|
(328
|
)
|
||
|
|
(15,516
|
)
|
|
(15,459
|
)
|
||
|
Total finite-lived assets, net
|
1,696
|
|
|
2,021
|
|
||
|
Indefinite-lived intangible assets - trade names
|
280
|
|
|
280
|
|
||
|
Total intangible assets, net
|
$
|
1,976
|
|
|
$
|
2,301
|
|
|
(1)
|
Includes the impact of foreign currency exchange rate fluctuations.
|
|
5.
|
Investment in Affiliate
|
|
6.
|
Debt
|
|
7.
|
Fair Value Measurements
|
|
8.
|
Preferred Shares
|
|
9.
|
Share Capital
|
|
Date issued
|
|
Contractual life (years)
|
|
Exercise price
|
|
Number outstanding
|
|
Expiration
|
|
|
May 2015
|
|
5
|
|
$800.00
|
|
4,200
|
|
|
May 31, 2020
|
|
October 2015
|
|
5
|
|
$466.00
|
|
2,010
|
|
|
October 14, 2020
|
|
December 2015
|
|
5
|
|
$500.00
|
|
5,138
|
|
|
December 15, 2020
|
|
December 2015
|
|
5
|
|
$216.00
|
|
7,500
|
|
|
December 4, 2020
|
|
March 2016
|
|
5
|
|
$500.00
|
|
150
|
|
|
March 4, 2021
|
|
August 2017
|
|
5
|
|
$42.00
|
|
37,500
|
|
|
August 11, 2022
|
|
August 2017
|
|
5
|
|
$42.00
|
|
11,876
|
|
|
August 16, 2022
|
|
August 2017
|
|
5
|
|
$42.00
|
|
25,625
|
|
|
August 22, 2022
|
|
April 2018
|
|
5
|
|
$5.60
|
|
111,563
|
|
|
April 17, 2023
|
|
March 2020
|
|
3
|
|
$0.60
|
|
1,205,820
|
|
|
March 23, 2023
|
|
|
|
|
|
|
|
1,411,382
|
|
(1)
|
|
|
(1)
|
Includes warrants to purchase up to
628,320
common shares, in the aggregate, outstanding to related parties at
March 31, 2020
.
|
|
10.
|
Equity Incentive Plans
|
|
|
|
Three Months
Ended March 31, |
||||||
|
|
|
2020
|
|
2019
|
||||
|
Cost of sales
|
|
$
|
—
|
|
|
$
|
693
|
|
|
Sales and marketing
|
|
2,014
|
|
|
10,313
|
|
||
|
Research and development
|
|
2,532
|
|
|
18,471
|
|
||
|
General and administrative
|
|
—
|
|
|
94,565
|
|
||
|
Total share-based compensation expense
|
|
$
|
4,546
|
|
|
$
|
124,042
|
|
|
11.
|
Net Loss per Share
|
|
|
Three Months
Ended March 31, |
||||
|
|
2020
|
|
2019
|
||
|
Common share purchase warrants
|
1,411,382
|
|
|
205,687
|
|
|
Convertible debt
|
1,116,500
|
|
|
—
|
|
|
Restricted stock not yet vested or released
|
—
|
|
|
114,066
|
|
|
Options outstanding
|
1,175
|
|
|
10,298
|
|
|
12.
|
Related Party Transactions
|
|
13.
|
Commitments and Contingencies
|
|
|
Deferred
Revenue |
||
|
Liability at January 1, 2020
|
$
|
1,109
|
|
|
Settlements made during the period
|
(271
|
)
|
|
|
Change in liability for warranties issued during the period
|
119
|
|
|
|
Change in liability for pre-existing warranties
|
—
|
|
|
|
Liability at March 31, 2020
|
$
|
957
|
|
|
Current liability
|
593
|
|
|
|
Non-current liability
|
364
|
|
|
|
Liability at March 31, 2020
|
$
|
957
|
|
|
14.
|
Subsequent Events
|
|
•
|
On June 1, 2020, the Company entered into a consulting agreement with GROUPE PARAMEUS CORP (“GROUPE P”) to provide consulting services for one year to the Company in the area of corporate finance, investor communications and financial and investor public relations. As compensation for GROUPE P’s services to be provided pursuant to the consulting agreement, in addition to a prepayment of $150,000 in cash, the Company granted 100,000 restricted stock awards, 100,000 common shares of the Company pursuant to the terms of Regulation D under the Securities Act of 1933, and a non-qualified stock option for the purchase of 50,000 common shares at an exercise price of $2.52 per share with a vest period over six months. On June 16, 2020, the Company issued 200,000 common shares to GROUPE P with a fair value of $504,000.
|
|
•
|
In the second quarter of 2020, the Company entered into various other consulting agreements for business advisory services. On June 16, 2020, the Company granted 130,000 of restricted stock awards and issued 130,000 common shares of the Company with a fair value of $327,000 in lieu of cash payment to certain business advisors for future services to be performed. The Company granted to the same business advisors, in the aggregate, non-qualified stock options for the purchase of 80,000 common shares with an exercise price of $2.52 per share for future services to be performed for the Company.
|
|
•
|
On May 15, 2020, the Company entered into an equity purchase agreement and registration rights agreement with Oasis Capital, LLC (“Oasis Capital”), to purchase from the Company up to
$11.0 million
common shares of the Company. Under the purchase agreement, the Company has the right to sell up to
$11.0 million
of its common shares to Oasis Capital over a 36-month period, upon satisfaction of the conditions in the Agreement, including the effectiveness of a resale registration statement being filed on Form S-1. The Company will control the timing and amount of any sales to Oasis Capital, and Oasis Capital is obligated to make purchases in accordance with the purchase agreement, upon certain terms and conditions being met. The purchase agreement, which contains a floor price of $1.58 per common share, allows the Company to fund its needs in a more expedient and cost-effective manner, on the pricing terms set forth in the purchase agreement. The equity line is designed to provide capital to the company as it is required.
|
|
•
|
On May 6, 2020, the Company filed articles of amendment to create a fourth series of preferred shares, being, an unlimited number of Series D Preferred Shares and to provide for the rights, privileges, restrictions and conditions attaching thereto. The Series D Preferred Shares are convertible into our common shares, at a conversion price equal to $0.65, subject to certain anti-dilution adjustments. Each shareholder of the Series D Preferred Shares, may, at any time, convert all or any part of the Series D Preferred Shares provided that after such conversion the common shares issuable, together with all the common shares held by the shareholder in the aggregate would not exceed 9.9% of the total number of outstanding common shares of the Company or in the aggregate no more than 800,000 common shares by all holders of Series D Preferred Shares. The Series D Preferred Shares do not have voting rights.
|
|
•
|
On April 30, 2020, the Company entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with two investors (the “Purchasers“) relating to the issuance and sale, in the aggregate, of
1,694,000
shares (the “Shares“) of the Company's subsequently established Series D Convertible Preferred Shares, no par value and warrants to purchase up to
1,694,000
common shares of the Company in a private placement transaction, in exchange for the assignment to the Company by the investors of certain promissory notes receivable held by the investors in an aggregate amount of
$1.1 million
. Subject to certain limitations, the warrants will be exercisable commencing on the six month anniversary at an exercise price equal to
$0.92
per common share, subject to adjustments as provided under the terms of the warrants, and are exercisable for a
five
years period. The warrants include a provision restricting the warrant holder from exercising it if the aggregate number of common shares held by the warrant holder equals or exceeds 5.0% of the issued and outstanding shares of the Company, calculated on a partially converted basis (i.e., assuming the conversion of all rights to receive common shares of the Company held by the warrant holder). On May 25, 2020, the Company converted 450,000 shares of the Series D Preferred Shares and issued 450,000 common shares of the Company. As a result of the conversion, one of the Purchasers, Gora Consulting Corp. (“Gora”) is classified as a related party to the Company. Gora participated in the Securities Purchase Agreement by acquiring 847,000 Shares and warrants to purchase 847,000 common shares, in exchange for the assignment to the Company certain promissory notes receivable held by Gora in an aggregate amount of $550,000. On May 25, 2020, Gora was issued 225,000 common shares. In addition, on April 21, 2020, the sole owner of Gora entered into a share purchase agreement with an employee of the Company and acquired 211,745 common shares of the Company.
|
|
•
|
On April 24, 2020, the Company entered into a consulting agreement (the “ROK Consulting Agreement”) with ROK Consulting Inc. (“ROK”) to provide consulting services to the Company in the area of corporate finance, investor communications and financial and investor public relations. As compensation for ROK’s services to be provided pursuant to the ROK Consulting Agreement, in addition to cash compensation, the Company has agreed to issue to ROK
375,000
common shares of the Company,
150,000
of such shares were due at signing of the ROK Consulting Agreement, while the remaining
225,000
shares are to be issued upon the completion of the three month term of the ROK Consulting Agreement. On June 19, 2020, the Company issued 150,000 common shares of the Company to ROK with a fair value of
$360,000
per the terms of the ROK Consulting Agreement.
|
|
•
|
On April 21, 2020, two investors entered into share purchase agreements to acquire in the aggregate 330,000 common shares of the Company. As a result of this transaction, 1542082 Ontario Limited (“1542082 Ontario”), an investor participating in the March 23, 2020 offering, will hold enough common shares of the Company be classified as a related party. 1542082 Ontario acquired 120,000 common shares of the Company in this transaction. In March 2020, 1542082 Ontario, paid directly
$150,000
to a business advisor on the behalf of the Company for a prepayment of future services to the Company.
|
|
•
|
Between April 7, 2020 and April 24, 2020, the Company converted
$377,000
of convertible debt and issued
580,580
common shares of the Company, of which $176,000 of debt converted was held by related parties, and they were issued in the aggregate
271,040
common shares.
|
|
•
|
On April 9, 2020, the Company received loan proceeds in the amount of $667,400 (the “PPP Funds”) and entered into a loan agreement with City National Bank pursuant to the CARES Act. The CARES Act was established in order to enable small businesses to pay employees during the economic slowdown caused by COVID-19 by providing forgivable loans to qualifying businesses for up to 2.5 times their average monthly payroll costs. The amount borrowed by the Company under the CARES Act is eligible to be forgiven provided that (a) the Company uses the PPP Funds during the eight week period after receipt thereof, and (b) the PPP Funds are only used to cover payroll costs (including benefits), rent, mortgage interest, and utility costs. The amount of loan forgiveness will be reduced if, among other reasons, the Company does not maintain staffing or payroll levels. Principal and interest payments on any unforgiven portion of the PPP Funds (the “PPP Loan”) will be deferred for six months and will accrue interest at a fixed annual rate of 1.0% and carry a two year maturity date. There is no prepayment penalty on the CARES Act Loan.
|
|
•
|
On February 13, 2020, the Company entered into a business advisory agreement with Torrington Financial Services Ltd (“Torrington”), a financial adviser to the Company. As a result of the March 23, 2020 transaction, Torrington and its entity under common control, Lallande Poydras Investment Partnership (“Lallande”), both participated in the below offering and are classified as a related party of the Company. On March 23, 2020, the Company entered into subscription agreements by and among the Company and the investors party thereto, including Torrington and Lallande, for the purchase and sale of
725
units (collectively, the “Units” and individually, a “Unit”) for aggregate gross proceeds of
$725,000
with
each Unit consisting of (a) a 6.0% convertible debenture in the principal amount of $1,000, which is convertible at $0.6495 per share into 1,540 common shares of the Company, and (b) a warrant to purchase 1,540 common shares of the Company exercisable at any time on or before the third year anniversary date at an exercise price of $0.60 per share
. The warrant includes a provision restricting the warrant holder from exercising it if the aggregate number of common shares held by the warrant holder equals or exceeds
5.0%
of the issued and outstanding shares of the Company, calculated on a partially converted basis (i.e., assuming the conversion of all rights to receive common shares of the Company held by the warrant holder). Torrington and Lallande participated in the offering and in the aggregate purchased
200
units, as well as for compensation for Torrington’s services, the Company issued to Torrington convertible debentures equal to
$58,000
and convertible into
89,320
common shares and a warrant for the purchase of 89,320 shares, with other terms substantially the same as the investors. The Company received cash proceeds of
$575,000
from the offering, and a participant of the offering paid directly
$150,000
to a financial consultant for a prepayment of future services to the Company. The Company intends to use the remaining proceeds from the offering for general corporate and working capital purposes.
|
|
|
Three Months
Ended March 31, |
||||
|
|
2020
|
|
2019
|
||
|
Revenue
|
100.0
|
%
|
|
100.0
|
%
|
|
Cost of revenue
|
54.2
|
|
|
67.4
|
|
|
Gross profit
|
45.8
|
|
|
32.6
|
|
|
Operating expenses:
|
|
|
|
|
|
|
Sales and marketing
|
30.1
|
|
|
21.3
|
|
|
Research and development
|
33.6
|
|
|
32.7
|
|
|
General and administrative
|
97.4
|
|
|
58.8
|
|
|
|
161.1
|
|
|
112.8
|
|
|
Loss from operations
|
(115.3
|
)
|
|
(80.2
|
)
|
|
Interest expense
|
(0.9
|
)
|
|
(6.8
|
)
|
|
Other income, net
|
6.9
|
|
|
0.4
|
|
|
Net loss
|
(109.3
|
)
|
|
(86.6
|
)
|
|
|
|
Three Months
Ended March 31, |
|
|
|||||||
|
|
|
2020
|
|
2019
|
|
Change
|
|||||
|
Gross profit
|
|
$
|
463
|
|
|
$
|
695
|
|
|
(33.4
|
)%
|
|
Gross margin
|
|
45.8
|
%
|
|
32.6
|
%
|
|
40.5
|
%
|
||
|
|
|
Maturity Date
|
|
Interest Rate
|
|
Amount Outstanding
|
||
|
Convertible debt
|
|
3/23/2023
|
|
6.0%
|
|
$
|
725
|
|
|
Line of credit
|
|
9/19/2020
|
|
6.5%
|
|
$
|
491
|
|
|
|
|
Three Months
Ended March 31, |
||||||
|
|
|
2020
|
|
2019
|
||||
|
Net cash used in operating activities
|
|
$
|
(439
|
)
|
|
$
|
(990
|
)
|
|
Net cash used in investing activities
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Net cash provided by financing activities
|
|
$
|
575
|
|
|
$
|
788
|
|
|
Item 1.
|
Legal Proceedings.
|
|
Exhibit
|
|
Filed
|
Incorporated by Reference
|
||
|
Number
|
Description
|
Herewith
|
Form
|
File No.
|
Date Filed
|
|
|
|
|
|
|
|
|
3.1
|
|
6-K
|
001-36532
|
3/25/2015
|
|
|
|
|
|
|
|
|
|
3.2
|
|
6-K
|
001-36532
|
7/17/2017
|
|
|
|
|
|
|
|
|
|
3.3
|
|
8-K
|
001-36532
|
10/2/2018
|
|
|
|
|
|
|
|
|
|
3.4
|
|
8-K
|
001-36532
|
10/5/2018
|
|
|
|
|
|
|
|
|
|
3.5
|
|
8-K
|
001-36532
|
11/5/2018
|
|
|
|
|
|
|
|
|
|
3.6
|
|
8-K
|
001-36532
|
11/14/2018
|
|
|
|
|
|
|
|
|
|
3.7
|
|
8-K
|
001-36532
|
7/12/2019
|
|
|
|
|
|
|
|
|
|
3.8
|
|
8-K
|
001-36532
|
11/8/2019
|
|
|
|
|
|
|
|
|
|
3.9
|
|
8-K
|
001-36532
|
5/8/2020
|
|
|
|
|
|
|
|
|
|
3.10
|
|
6-K
|
001-36532
|
7/17/2017
|
|
|
|
|
|
|
|
|
|
3.11
|
|
6-K
|
001-36532
|
5/12/2017
|
|
|
|
|
|
|
|
|
|
4.1
|
|
8-K
|
001-36532
|
3/27/2020
|
|
|
|
|
|
|
|
|
|
4.2
|
|
8-K
|
001-36532
|
3/27/2020
|
|
|
|
|
|
|
|
|
|
4.3
|
|
8-K
|
001-36532
|
5/4/2020
|
|
|
|
|
|
|
|
|
|
10.1
|
|
8-K
|
001-36532
|
3/27/2020
|
|
|
|
|
|
|
|
|
|
10.2
|
|
8-K
|
001-36532
|
5/4/2020
|
|
|
|
|
|
|
|
|
|
10.3
|
|
10-K
|
001-36532
|
5/14/2020
|
|
|
|
|
|
|
|
|
|
10.4
|
|
10-K
|
001-36532
|
5/14/2020
|
|
|
|
|
|
|
|
|
|
10.5
|
|
10-K
|
001-36532
|
5/14/2020
|
|
|
|
|
|
|
|
|
|
10.6
|
|
8-K
|
001-36532
|
5/19/2020
|
|
|
|
|
|
|
|
|
|
10.7
|
|
8-K
|
001-36532
|
5/19/2020
|
|
|
|
|
|
|
|
|
|
10.8
|
|
S-1
|
333-238531
|
5/20/2020
|
|
|
|
|
|
|
|
|
|
Exhibit
|
|
Filed
|
Incorporated by Reference
|
||
|
Number
|
Description
|
Herewith
|
Form
|
File No.
|
Date Filed
|
|
10.9
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
10.10
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
10.11
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
10.12
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
31.1
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
31.2
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
32
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
101.INS
|
XBRL Instance Document
|
X
|
|
|
|
|
|
|
|
|
|
|
|
101.SCH
|
XBRL Taxonomy Extension Schema
|
X
|
|
|
|
|
|
|
|
|
|
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase
|
X
|
|
|
|
|
|
|
|
|
|
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase
|
X
|
|
|
|
|
|
|
|
|
|
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase
|
X
|
|
|
|
|
|
|
|
|
|
|
|
101.PRE
|
XBRL Taxonomy Presentation Linkbase
|
X
|
|
|
|
|
|
|
|
Sphere 3D Corp.
|
|
|
|
|
|
|
|
|
Date:
|
June 24, 2020
|
|
By:
|
/s/ Peter Tassiopoulos
|
|
|
|
|
|
Peter Tassiopoulos
Chief Executive Officer
(Principal Executive Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|